Cargando…
The Novel MyD88 Inhibitor TJ-M2010-5 Protects Against Hepatic Ischemia-reperfusion Injury by Suppressing Pyroptosis in Mice
. With the development of medical technology and increased surgical experience, the number of patients receiving liver transplants has increased. However, restoration of liver function in patients is limited by the occurrence of hepatic ischemia-reperfusion injury (IRI). Previous studies have report...
Autores principales: | Zou, Zhimiao, Shang, Runshi, Zhou, Liang, Du, Dunfeng, Yang, Yang, Xie, Yalong, Li, Zeyang, Zhao, Minghui, Jiang, Fengchao, Zhang, Limin, Zhou, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875839/ https://www.ncbi.nlm.nih.gov/pubmed/36226835 http://dx.doi.org/10.1097/TP.0000000000004317 |
Ejemplares similares
-
TJ-M2010-5, a novel CNS drug candidate, attenuates acute cerebral ischemia-reperfusion injury through the MyD88/NF-κB and ERK pathway
por: Li, Zeyang, et al.
Publicado: (2022) -
MyD88 deficiency aggravates the severity of acute pancreatitis by promoting MyD88-independent TRIF pathway-mediated necrosis
por: Yang, Du-Jiang, et al.
Publicado: (2022) -
Role of MyD88 in Adenovirus Keratitis
por: Zhou, Xiaohong, et al.
Publicado: (2016) -
Ischemia-Reperfusion Lung Injury Is Attenuated in MyD88-Deficient Mice
por: Altemeier, William A., et al.
Publicado: (2013) -
MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity
por: Saikh, Kamal U.
Publicado: (2021)